Novel hormone therapy and coordination of care in high-risk biochemically recurrent prostate cancer
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel hormone therapy and coordination of care in high-risk biochemically recurrent prostate cancer
Authors
Keywords
-
Journal
CANCER TREATMENT REVIEWS
Volume -, Issue -, Pages 102630
Publisher
Elsevier BV
Online
2023-09-27
DOI
10.1016/j.ctrv.2023.102630
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- LBA02-09 EMBARK: A PHASE 3 RANDOMIZED STUDY OF ENZALUTAMIDE OR PLACEBO PLUS LEUPROLIDE ACETATE AND ENZALUTAMIDE MONOTHERAPY IN HIGH-RISK BIOCHEMICALLY RECURRENT PROSTATE CANCER
- (2023) Neal D. Shore et al. JOURNAL OF UROLOGY
- Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer
- (2022) Andrew J. Armstrong et al. JOURNAL OF CLINICAL ONCOLOGY
- Factors influencing the quality and functioning of oncological multidisciplinary team meetings: results of a systematic review
- (2022) Janneke E. W. Walraven et al. BMC HEALTH SERVICES RESEARCH
- Clinical impact of PSMA PET in patients with biochemically recurrent prostate cancer after locoregional definitive therapy.
- (2022) Avanti Gulhane et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase III double blinded study of early intervention after radical prostatectomy with androgen deprivation therapy with darolutamide versus placebo in men at highest risk of prostate cancer metastasis by genomic stratification (ERADICATE).
- (2022) Alicia K. Morgans et al. JOURNAL OF CLINICAL ONCOLOGY
- Defining Oligometastatic Disease in the New Era of PSMA-PET Imaging for Primary Staging of Prostate Cancer
- (2022) Samuel J. Galgano et al. Cancers
- More than Meets the Eye: Using Textural Analysis and Artificial Intelligence as Decision Support Tools in Prostate Cancer Diagnosis—A Systematic Review
- (2022) Teodora Telecan et al. Journal of Personalized Medicine
- LBA63 PRESTO: A phase III, open-label study of androgen annihilation in patients (pts) with high-risk biochemically relapsed prostate cancer (AFT-19)
- (2022) R. Aggarwal et al. ANNALS OF ONCOLOGY
- Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials
- (2022) Matthew P. Deek et al. JOURNAL OF CLINICAL ONCOLOGY
- Addition of Metastasis-Directed Therapy to Intermittent Hormone Therapy for Oligometastatic Prostate Cancer (EXTEND): A Multicenter, Randomized Phase II Trial
- (2022) C. Tang et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Addressing Challenges and Controversies in the Management of Prostate Cancer with Multidisciplinary Teams
- (2022) Neal D. Shore et al. Targeted Oncology
- Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update
- (2021) Katherine S. Virgo et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of Systemic Treatments for Metastatic Castration-Sensitive Prostate Cancer
- (2021) Lin Wang et al. JAMA Oncology
- Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase 3, Multicenter Study
- (2021) Michael J. Morris et al. CLINICAL CANCER RESEARCH
- Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer
- (2021) Felix Y. Feng et al. JAMA Oncology
- 18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial
- (2021) Ashesh B Jani et al. LANCET
- A narrative review of oligometastatic prostate cancer—an evolving paradigm
- (2021) Kobika Sritharan et al. Annals of Palliative Medicine
- LBA4 Abiraterone acetate plus prednisolone (AAP) with or without enzalutamide (ENZ) added to androgen deprivation therapy (ADT) compared to ADT alone for men with high-risk non-metastatic (M0) prostate cancer (PCa): Combined analysis from two comparisons in the STAMPEDE platform protocol
- (2021) G. Attard et al. ANNALS OF ONCOLOGY
- The European Association of Urology Biochemical Recurrence Risk Groups Predict Findings on PSMA PET in Patients with Biochemically Recurrent Prostate Cancer after Radical Prostatectomy
- (2021) LIANG DONG et al. JOURNAL OF NUCLEAR MEDICINE
- Dynamic multidisciplinary team discussions can improve the prognosis of metastatic castration‐resistant prostate cancer patients
- (2021) Sha Zhu et al. PROSTATE
- A phase 3 randomised study of enzalutamide plus leuprolide and enzalutamide monotherapy in high-risk non-metastatic hormone-sensitive prostate cancer with rising PSA after local therapy: EMBARK study design
- (2021) Stephen J Freedland et al. BMJ Open
- Current Opinion Regarding Multidisciplinary Cancer Clinic Utilization for the Management of Prostate Cancer
- (2021) Daniel J. Lama et al. Journal of Clinical Imaging Science
- Abiraterone acetate plus prednisone in non-metastatic biochemically recurrent castration-naïve prostate cancer
- (2021) Nicholas Spetsieris et al. EUROPEAN JOURNAL OF CANCER
- Association of Inherited Mutations in DNA Repair Genes with Localized Prostate Cancer
- (2021) Daniel J. Lee et al. EUROPEAN UROLOGY
- PSMA PET Validates Higher Rates of Metastatic Disease for European Association of Urology Biochemical Recurrence Risk Groups: An International Multicenter Study
- (2021) Justin Ferdinandus et al. JOURNAL OF NUCLEAR MEDICINE
- Appropriate Use Criteria for Prostate-Specific Membrane Antigen PET Imaging
- (2021) Hossein Jadvar et al. JOURNAL OF NUCLEAR MEDICINE
- Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol
- (2021) Gerhardt Attard et al. LANCET
- Oligometastatic Disease Detection with 68Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer Patients (HSPC) with Biochemical Recurrence after Radical Prostatectomy: Predictive Factors and Clinical Impact
- (2021) Carlos Artigas et al. Cancers
- ECCO Essential Requirements for Quality Cancer Care: Prostate cancer
- (2020) Maurizio Brausi et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
- (2020) Silke Gillessen et al. EUROPEAN UROLOGY
- Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline
- (2020) Edouard J. Trabulsi et al. JOURNAL OF CLINICAL ONCOLOGY
- Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence (STOMP): Five-year results of a randomized phase II trial.
- (2020) Piet Ost et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of 68Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single Center Study
- (2020) Ida Sonni et al. JOURNAL OF NUCLEAR MEDICINE
- RTOG 3506 (STEEL): A study of salvage radiotherapy with or without enzalutamide in recurrent prostate cancer following surgery.
- (2020) Edwin Melencio Posadas et al. JOURNAL OF CLINICAL ONCOLOGY
- Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer
- (2020) Robert T. Dess et al. JAMA Oncology
- Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer
- (2020) Ryan Phillips et al. JAMA Oncology
- Deep learning detection of prostate cancer recurrence with 18F-FACBC (fluciclovine, Axumin®) positron emission tomography
- (2020) Jong Jin Lee et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II—2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer
- (2020) Philip Cornford et al. EUROPEAN UROLOGY
- Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I
- (2020) William T. Lowrance et al. JOURNAL OF UROLOGY
- Assessment of Postprostatectomy Radiotherapy as Adjuvant or Salvage Therapy in Patients With Prostate Cancer
- (2020) Sean Sachdev et al. JAMA Oncology
- A new risk stratification system of prostate cancer to identify high-risk biochemical recurrence patients
- (2020) Xiangkun Wu et al. Translational Andrology and Urology
- EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
- (2020) Nicolas Mottet et al. EUROPEAN UROLOGY
- Referral rates to multidisciplinary team meetings: Is there disparity between tumour streams?
- (2019) Daisy Atwell et al. Journal of Medical Imaging and Radiation Oncology
- Should we involve patients more actively? Perspectives of the multidisciplinary team on shared decision-making for older patients with metastatic castration-resistant prostate cancer
- (2019) Isabel B. de Angst et al. Journal of Geriatric Oncology
- Effect of Adding Docetaxel to Androgen-Deprivation Therapy in Patients With High-Risk Prostate Cancer With Rising Prostate-Specific Antigen Levels After Primary Local Therapy
- (2019) Stéphane Oudard et al. JAMA Oncology
- Radical prostatectomy or radiotherapy for high- and very high-risk prostate cancer: a multidisciplinary prostate cancer clinic experience of patients eligible for either treatment
- (2019) Chad A. Reichard et al. BJU INTERNATIONAL
- Interim results from a phase 2 study of olaparib (without ADT) in men with biochemically-recurrent prostate cancer after prostatectomy, with integrated biomarker analysis.
- (2019) Emmanuel S. Antonarakis et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant And Salvage Radiotherapy After Prostatectomy: Aua/Astro Guideline Amendment 2018
- (2019) Thomas M. Pisansky et al. JOURNAL OF UROLOGY
- A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA)
- (2019) Roche Kapoor et al. BMC CANCER
- 18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial
- (2019) Jeremie Calais et al. LANCET ONCOLOGY
- Impact of adherence to multidisciplinary recommendations for adjuvant treatment in radical prostatectomy patients with high risk of recurrence
- (2019) Sophie Knipper et al. Clinical Genitourinary Cancer
- Molecular Profiling of Oligometastases and Artificial Intelligence-based Model for Predicting Treatment Outcome in Advance Prostate Cancer
- (2019) N. Heidari et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Contemporary prostate cancer treatment choices in multidisciplinary clinics referenced to national trends
- (2019) Chad Tang et al. CANCER
- Differences in Tumor Microenvironment Dictate T Helper Lineage Polarization and Response to Immune Checkpoint Therapy
- (2019) Shiping Jiao et al. CELL
- Analysis of 105.000 patients with cancer: have they been discussed in oncologic multidisciplinary team meetings? A nationwide population-based study in the Netherlands
- (2019) J.E.W. Walraven et al. EUROPEAN JOURNAL OF CANCER
- Clinical Utility of a Genomic Classifier in Men Undergoing Radical Prostatectomy: The PRO-IMPACT Trial
- (2019) John L. Gore et al. Practical Radiation Oncology
- Molecular Biomarkers in Localized Prostate Cancer: ASCO Guideline
- (2019) Scott E. Eggener et al. JOURNAL OF CLINICAL ONCOLOGY
- Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial
- (2019) Christian Carrie et al. LANCET ONCOLOGY
- Prostate cancer management at an Italian tertiary referral center: does multidisciplinary team meeting influence diagnostic and therapeutic decision-making process? A snapshot of the everyday clinical practice
- (2019) Stefano De Luca et al. Minerva Urologica E Nefrologica
- A multidisciplinary team-oriented intervention to increase guideline recommended care for high-risk prostate cancer: A stepped-wedge cluster randomised implementation trial
- (2018) Bernadette Brown et al. Implementation Science
- Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial
- (2018) Piet Ost et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options
- (2018) Martin G. Sanda et al. JOURNAL OF UROLOGY
- Could 68-Ga PSMA PET/CT become a new tool in the decision-making strategy of prostate cancer patients with biochemical recurrence of PSA after radical prostatectomy? A preliminary, monocentric series
- (2018) Berardino De Bari et al. Radiologia Medica
- A phase 3 study of androgen annihilation in high-risk biochemically relapsed prostate cancer: An Alliance Foundation trial (AFT-19).
- (2018) Rahul Raj Aggarwal et al. JOURNAL OF CLINICAL ONCOLOGY
- A Clinician’s Guide to Next Generation Imaging in Patients With Advanced Prostate Cancer (Prostate Cancer Radiographic Assessments for Detection of Advanced Recurrence [RADAR] III)
- (2018) E. David Crawford et al. JOURNAL OF UROLOGY
- Oligometastatic prostate cancer: Reality or figment of imagination?
- (2018) Corey C. Foster et al. CANCER
- Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review
- (2018) Thomas Van den Broeck et al. EUROPEAN UROLOGY
- Time Interval to Biochemical Failure as a Surrogate End Point in Locally Advanced Prostate Cancer: Analysis of Randomized Trial NRG/RTOG 9202
- (2018) James J. Dignam et al. JOURNAL OF CLINICAL ONCOLOGY
- 68Ga-PSMA 11 ligand PET imaging in patients with biochemical recurrence after radical prostatectomy – diagnostic performance and impact on therapeutic decision-making
- (2017) B. Grubmüller et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Aiming for a holistic integrated service for men diagnosed with prostate cancer – Definitions of standards and skill sets for nurses and allied healthcare professionals
- (2017) Alastair D. Lamb et al. European Journal of Oncology Nursing
- Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic Disease
- (2017) Daniel E. Spratt et al. JOURNAL OF CLINICAL ONCOLOGY
- Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer
- (2017) William U. Shipley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhanced radiosensitization of enzalutamide via schedule dependent administration to androgen-sensitive prostate cancer cells
- (2017) Maryam Ghashghaei et al. PROSTATE
- Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy
- (2017) Shuang G. Zhao et al. JAMA Oncology
- Models of Care and NCCN Guideline Adherence in Very-Low-Risk Prostate Cancer
- (2017) Ayal A. Aizer et al. Journal of the National Comprehensive Cancer Network
- Sequencing of Sipuleucel-T and Androgen Deprivation Therapy in Men with Hormone-Sensitive Biochemically Recurrent Prostate Cancer: A Phase II Randomized Trial
- (2016) Emmanuel S. Antonarakis et al. CLINICAL CANCER RESEARCH
- Role of Hormonal Treatment in Prostate Cancer Patients with Nonmetastatic Disease Recurrence After Local Curative Treatment: A Systematic Review
- (2016) Roderick C.N. van den Bergh et al. EUROPEAN UROLOGY
- Cardiovascular Mortality Following Short-term Androgen Deprivation in Clinically Localized Prostate Cancer: An Analysis of RTOG 94-08
- (2016) Justin C. Voog et al. EUROPEAN UROLOGY
- Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial
- (2016) Gillian M Duchesne et al. LANCET ONCOLOGY
- A prospective cohort study of treatment decision-making for prostate cancer following participation in a multidisciplinary clinic
- (2016) Lauren M. Hurwitz et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- A National Multicenter Phase 2 Study of Prostate-specific Antigen (PSA) Pox Virus Vaccine with Sequential Androgen Ablation Therapy in Patients with PSA Progression: ECOG 9802
- (2015) Robert S. DiPaola et al. EUROPEAN UROLOGY
- Beyond the Immune Suppression: The Immunotherapy in Prostate Cancer
- (2015) Ida Silvestri et al. Biomed Research International
- Uro-oncology multidisciplinary meetings at an Australian tertiary referral centre - impact on clinical decision-making and implications for patient inclusion
- (2014) Kenny Rao et al. BJU INTERNATIONAL
- Establishment of a new prostate cancer multidisciplinary clinic: Format and initial experience
- (2014) Debasish Sundi et al. PROSTATE
- Medical Oncology Consultation and Minimization of Overtreatment in Men With Low-Risk Prostate Cancer
- (2014) Ayal A. Aizer et al. Journal of Oncology Practice
- Quality of Life After Sipuleucel-T Therapy: Results From a Randomized, Double-blind Study in Patients With Androgen-dependent Prostate Cancer
- (2013) Tomasz M. Beer et al. UROLOGY
- Impact of a Prostate Multidisciplinary Clinic Program on Patient Treatment Decisions and on Adherence to NCCN Guidelines
- (2012) Howard Korman et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Hematological changes during androgen deprivation therapy
- (2012) Mathis Grossmann et al. ASIAN JOURNAL OF ANDROLOGY
- Preoperative characteristics of high-Gleason disease predictive of favourable pathological and clinical outcomes at radical prostatectomy
- (2012) Phillip M. Pierorazio et al. BJU INTERNATIONAL
- Multidisciplinary Care and Pursuit of Active Surveillance in Low-Risk Prostate Cancer
- (2012) Ayal A. Aizer et al. JOURNAL OF CLINICAL ONCOLOGY
- Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy
- (2012) Juanita M. Crook et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinically relevant fatigue in men with hormone-sensitive prostate cancer on long-term androgen deprivation therapy
- (2011) D. J. Storey et al. ANNALS OF ONCOLOGY
- The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-up
- (2011) Emmanuel S. Antonarakis et al. BJU INTERNATIONAL
- Randomized Trial of Autologous Cellular Immunotherapy with Sipuleucel-T in Androgen-Dependent Prostate Cancer
- (2011) T. M. Beer et al. CLINICAL CANCER RESEARCH
- Enhancing Prostate Cancer Care Through the Multidisciplinary Clinic Approach: A 15-Year Experience
- (2010) Leonard G. Gomella et al. Journal of Oncology Practice
- Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy: Observational Study of Veterans With Prostate Cancer
- (2009) N. L. Keating et al. JNCI-Journal of the National Cancer Institute
- A multidisciplinary approach to the management of urologic malignancies: Does it influence diagnostic and treatment decisions?
- (2009) Raj Kurpad et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Cardiovascular Mortality and Duration of Androgen Deprivation for Locally Advanced Prostate Cancer: Analysis of RTOG 92-02
- (2008) Jason A. Efstathiou et al. EUROPEAN UROLOGY
- Cardiovascular Mortality After Androgen Deprivation Therapy for Locally Advanced Prostate Cancer: RTOG 85-31
- (2008) Jason A. Efstathiou et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search